TRPHARM's AI-powered project wins Gold Award

TRPharm received a Gold Award for its project aimed at raising awareness on breast cancer, rare diseases and supportive treatments. TRPharm, one of the leading companies in the healthcare sector, won the Gold Award in the "Best Marketing Project" category at the Turkey Golden Brand Awards with its innovative "Artificial Intelligence-Supported Health Awareness Simulation Project". The project aims to increase awareness in the target audience regarding breast cancer, rare diseases and supportive treatments. The winners of the Turkey Golden Brand Awards, one of Turkey's most prestigious business awards, have been announced. TRPharm, a leading healthcare company that provides pharmaceutical and non-pharmaceutical innovative solutions in oncology, haematology, immunology, metabolism and rare diseases as well as in ophthalmology, paediatric health and medical aesthetics, was recognized with a Gold Award at the Turkey Golden Brand Awards in the "Best Marketing Project" category within the "Healthcare Solutions" sector for its "Artificial Intelligence-Supported Health Awareness Simulation Project". Emphasizing that TRPharm not only provides solutions to health problems but also contributes to everyone living a healthier life, TRPharm General Director İsmet İnce stated: "The 'Artificial Intelligence-Supported Health Awareness Simulation Project' that won us this valuable award is proof of this… It is also a reflection of our belief that pushing boundaries through innovation and technology can make a real difference in human life… With our project, we aim to depict the difficulties experienced by physicians in breast cancer, rare diseases and patients using lactation enhancement products in the supportive treatment group through artificial intelligence-supported visuals; to increase awareness, to demonstrate how symptoms are reduced with proper treatment and to show improvements in quality of life. This award represents not only TRPharm's achievements but also Turkey's potential and capabilities in the healthcare sector. I would like to reiterate our belief that our country needs to make greater investments in such health technology innovations." The "Artificial Intelligence-Supported Health Awareness Simulation Project" that brought the award to TRPharm aims to increase awareness in the target audience regarding breast cancer, rare diseases and supportive treatments. The project presents an artificial intelligence-supported simulation to demonstrate how symptoms are reduced with proper treatment and improvements in quality of life, and also reflects TRPharm's vision in oncology-haematology, rare diseases and supportive treatment groups. The vision of bringing these groups together under one roof manifests itself in the project through a virtual apartment setting. This innovative approach also aims to create a family environment where individuals struggling with different health conditions can find support.